Prescribing Information for ▼PAXLOVID (nirmatrelvir / ritonavir) can be found here: Great Britain and Northern Ireland. Adverse event reporting information can be found at the bottom of the page. Please note, there are differences between the SmPC for Northern Ireland and the SmPC for Great Britain. Please refer to the appropriate SmPC depending on where you are based.
Paxlovid has a Conditional Marketing Authorisation in Great Britain. A Conditional Marketing Authorisation means that further evidence on this medicinal product is awaited. New information on this medicinal product will be reviewed when any relevant information of significance becomes available and at least every year and the product information will be updated as necessary.
Great Britain
Northern Ireland
For HCPs
Mechanism of Action Flashcard
A digital flashcard providing educational information about the Paxlovid Mechanism of Action.
Download
For HCPs
Patient Case Study: Reducing Health Inequalities
A two-page case study on identifying and educating patients at high risk of severe COVID-19 progression at Stonyhill Medical Practice in Blackpool.
Download
For HCPs
Patient Case Study: Reducing Health Inequalities
A two-page case study on identifying and educating patients at high risk of severe COVID-19 progression at Stonyhill Medical Practice in Blackpool.
Download
For HCPs
PAXLOVID Dosing Guide
A guide for NI healthcare professionals highlighting dosing information for PAXLOVID.
Download
Prof Mark Nelson reviews the impact COVID-19 is still having on the NHS and the groups of patients who are most at risk of developing severe COVID-19.
PAXLOVID contains nirmatrelvir, a protease inhibitor designed to target the main SARS-CoV-2 protease and inhibit replication by preventing proteolysis from occurring.1,2
Adverse Events
Adverse Events should be reported. Reporting forms and information can be found at https://coronavirus-yellowcard.mhra.gov.uk/ or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024